Activating protein 1-mediated cyclooxygenase-2 expression is independent of N-terminal phosphorylation of c-Jun

Molecular Pharmacology

Volumn 67, Issue 6, 2005, Pages 2057-2069

  Chen, Lei Chin ^a   Chen, Ben Kuen ^a   Chang, Wen Chang ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; PROTEIN C FOS; PROTEIN C JUN; SYNAPSIN I; TRANSCRIPTION FACTOR; MEMBRANE PROTEIN; PEPTIDE FRAGMENT; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR AP 1;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRECIPITATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; BIOSYNTHESIS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TRANSACTIVATION; TUMOR CELL LINE;

CELL LINE, TUMOR; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MEMBRANE PROTEINS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS C-JUN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1;

EID: 21744449641     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.010900     Document Type: Article

References (39)

1. Andrews N and Faller D (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499.
2. Angel P and Karin M (1991) The role of Jun, Fos and the AP-1 complex in cellproliferation and transformation. Biochim Biophys Acta 10:129-157.
3. Bannister AJ, Oehler T, Wilhelm D, Angel P, and Kouzarides T (1995) Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 11:2509-2514.
4. Behre G, Whitmarsh AJ, Coghlan MP, Hoang T, Carpenter CL, Zhang D-E, Davis RJ, and Tenen DG (1999) c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J Biol Chem 274:4939-4946.
5. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681-13686.
6. Binetruy B, Smeal T, and Karin M (1991) Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature (Lond) 351:122-127.
7. Boyle WJ, Smeal T, Defize LH, Angel P, Woodgett JR, Karin M, and Hunter T (1991) Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64:573-584.
8. Brown PH, Chen TK, and Birrer MJ (1994) Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9:791-799.
9. Chan HM and La Thangue NB (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 114:2363-2373.
10. Chandrasekharan NV, Dai H, Roos KLT, Evanson NK, Tomsik J, Elton TS, and Simmons DL (2002) From the cover: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc Natl Acad Sci USA 99:13926-13931.
11. Chen LC, Chen BK, Chang JM, and Chang WC (2004) Essential role of c-Jun induction and coactivator p300 in epidermal growth factor-induced gene expression of cyclooxygenase-2 in human epidermoid carcinoma A431 cells. Biochim Biophys Acta 1683:38-48.
12. Chinenov Y and Kerppola TK (2001) Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20:2438-2452.
13. Cruzalegui FH, Hardingham GE, and Bading H (1999) c-Jun functions as a calciumregulated transcriptional activator in the absence of JNK/SAPK1 activation. EMBO (Eur Mol Biol Organ) J 18:1335-1344.
14. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, and Davis RJ (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
15. Dunn C, Wiltshire C, MacLaren A, and Gillespie DA (2002) Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell Signal 14:585-593.
16. Evans JF and Kargman SL (2004) Cancer and cyclooxygenase-2 (COX-2) inhibition. Curr Pharm Des 10:627-634.
17. Faggioli L, Costanzo C, Donadelli M, and Palmieri M (2004) Activation of the interleukin-6 promoter by a dominant negative mutant of c-Jun. Biochim Biophys Acta 1692:17-24.
18. Grimm C, Wenzel A, Behrens A, Hafezi F, Wagner EF, and Reme CE (2001) AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun. Cell Death Differ 8:859-867.
19. Herschman HR (1996) Prostaglandin synthase 2. Biochim Biophys Acta 299:125-140.
20. Higuchi R, Krummel B, and Saiki RK (1988) A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res 16:7351-7367.
21. Hinz B and Brune K (2002) Cyclooxygenase-2-10 years later. J Pharmacol Exp Ther 300:367-375.
22. Jooss KU, Funk M, and Muller R (1994) An autonomous N-terminal transactivation domain in Fos protein plays a crucial role in transformation. EMBO (Eur Mol Biol Organ) J 13:1467-1475.
23. Kuitert LME, Bergmann M, Adcock IM, and Barnes PJ (1997) Evidence for involvement of NF-κB in the transcriptional control of COX-2 gene expression by IL-1β. Biochem Biophys Res Commun 237:28-32.
24. Kujubu D, Fletcher B, Varnum B, Lim R, and Herschman H (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266:12866-12872.
25. Kulmacz RJ and Wu KK (1989) Topographic studies of microsomal and pure prostaglandin H synthase. Arch Biochem Biophys 268:502-515.
26. Lin A, Frost J, Deng T, Smeal T, al-Alawi N, Kikkawa U, Hunter T, Brenner D, and Karin M (1992) Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. Cell 70:777-789.
27. McBride K and Nemer M (1998) The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers. Mol Cell Biol 18:5073-5081.
28. Monje P, Marinissen MJ, and Gutkind JS (2003) Phosphorylation of the carboxylterminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol Cell Biol 23:7030-7043.
29. Morton S, Davis RJ, McLaren A, and Cohen P (2003) A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO (Eur Mol Biol Organ) J 22:3876-3886.
30. Saccani S, Pantano S, and Natoli G (2001) Two waves of nuclear factor {kappa}B recruitment to target promoters. J Exp Med 193:1351-1360.
31. Smeal T, Binetruy B, Mercola DA, Birrer M, and Karin M (1991) Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature (Lond) 354:494-496.
32. Struhl K (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12:599-606.
33. Tohnai N (2002) Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 68-69:95-114.
34. van Dam H and Castellazzi M (2001) Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene 20:2453-2464.
35. Vogt PK (2001) Jun, the oncoprotein. Oncogene 20:2365-2377.
36. Vries RG, Prudenziati M, Zwartjes C, Verlaan M, Kalkhoven E, and Zantema A (2001) A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300. EMBO (Eur Mol Biol Organ) J 20:6095-6103.
37. Xie W and Herschman HR (1996) Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J Biol Chem 271:31742-31748.
38. Zagariya A, Mungre S, Lovis R, Birrer M, Ness S, Thimmapaya B, and Pope R (1998) Tumor necrosis factor alpha gene regulation: enhancement of C/EBPbeta-induced activation by c-Jun. Mol Cell Biol 18:2815-2824.
39. Zhu Y, Saunders MA, Yeh H, Deng WG, and Wu KK (2002) Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins. J Biol Chem 277:6923-6928.